Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Kibsgård TJ, Gerdhem P, Diarbakerli E, Randers EM(2026) Minimally Invasive Sacroiliac Joint Fusion Compared with Sham Operation (SIFSO Trial): A Concise Follow-up, at 2 Years, of a Previous Report J Bone Joint Surg Am(in press) DOI 10.2106/JBJS.25.00918, PubMed 42154897
Requena Osete J, Szabo A, Akkouh IA, Falck M, Ievglevskyi O, Vandenberghe M, Vatne GH, Fjerdingstad HB, Frei E, Hughes T, Fyhn M, Smeland OB, Steen NE, Ueland T, Andreassen OA, Djurovic S(2026) MIF modulates impaired astrocyte distribution in schizophrenia cortical spheroids Brain(in press) DOI 10.1093/brain/awag181, PubMed 42153336
Fagerland MW(2026) The win ratio: a valuable addition to the toolbox of cardiovascular trialists Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvag036, PubMed 42150844